Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Testosterone (TRT) wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Finasteride and Testosterone (TRT) have evidence — compare verdict strength side-by-side.
1 mg once daily for male pattern hair loss (Propecia); 5 mg once daily for benign prostatic hyperplasia (Proscar). A prescription drug — use under a clinician.
any
Oral tablet (1 mg for hair, 5 mg for BPH)
Prescription-only and clinician-directed — this is a controlled substance, NOT a self-administered supplement, and we do not provide a non-medical dosing protocol. For context only: TRT for diagnosed hypogonadism is titrated to a mid-normal testosterone level. Intramuscular testosterone esters (cypionate/enanthate) are commonly dosed around 50–100 mg weekly (or ~100–200 mg every 2 weeks); long-acting testosterone undecanoate is dosed less frequently. Transdermal gels (~50–100 mg/day applied) and subcutaneous injection are alternative routes. Supraphysiologic anabolic-steroid doses are far higher, illegal, and dangerous — not a regimen this library endorses.
any
Clinician-prescribed testosterone (intramuscular ester or transdermal gel) for diagnosed hypogonadism — controlled substance, prescription-only
3-12 months to visible effect
Months to years
Throughout use; sometimes persistent
Throughout use
Weeks to months
Months
Months
Throughout use
Finasteride in the treatment of men with androgenetic alopecia.
Journal of the American Academy of Dermatology (1998) · Rct · n=1553
Pivotal double-blind randomized, placebo-controlled trials of finasteride 1 mg/day for male pattern hair loss
Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
European journal of dermatology : EJD (2002) · Rct · n=1553
Five-year placebo-controlled extension of the pivotal Phase III hair-loss trials
The impact of monotherapies for male androgenetic alopecia: A network meta-analysis study.
Journal of cosmetic dermatology (2024) · Meta analysis
Network meta-analysis of monotherapies for male androgenetic alopecia
Effects of Testosterone Treatment in Older Men.
The New England journal of medicine (2016) · Rct · n=790
The coordinated Testosterone Trials (TTrials) — seven randomized, double-blind, placebo-controlled trials in 790 men aged 65+ with confirmed low testosterone and symptoms, treated with testosterone gel for one year
Cardiovascular Safety of Testosterone-Replacement Therapy.
The New England journal of medicine (2023) · Rct · n=5246
TRAVERSE: a randomized, double-blind, placebo-controlled non-inferiority trial of transdermal testosterone in 5246 middle-aged and older hypogonadal men with high cardiovascular risk — the largest TRT cardiovascular-safety trial
Safety and Efficacy of Testosterone Therapy on Musculoskeletal Health and Clinical Outcomes in Men: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Endocrine practice (2023) · Meta analysis
Systematic review and meta-analysis of 16 randomized placebo-controlled trials (1728 men, mean age 77) of testosterone therapy on musculoskeletal outcomes
Testosterone (TRT) has a higher evidence score (5.6/10 vs 5.5/10) and wins in 2 of 3 categories.
No known interactions between Finasteride and Testosterone (TRT) have been documented in our database. However, always consult a healthcare provider before combining supplements.